Stereotactic Body Radiation Therapy Plus Chemotherapy Improves Survival Among Stage 4 Lung Cancer Patients
A clinical trial that combined stereotactic body radiation therapy with a specific chemotherapy regimen more than doubled survival rates for certain stage 4 lung cancer patients, scientists report.
Source: ScienceDaily Headlines - Category: Science Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Lung Cancer | Radiation Therapy | Science